Back to search
FDAFDA · Food and drugs·Recall number D-1677-2012

Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781- 5249-92,

Published September 26, 2012 · Recall initiated: September 12, 2012

Summary

FDA records drug Class III recall D-1677-2012, published September 26, 2012 and initiated September 12, 2012. Recalling firm: Sandoz Incorporated; Status: Terminated; Reported quantity: 43,060 x 90 count bottles; Lot: Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Incorporated
Distributor
Nationwide
Lot
Lot numbers: BJ3338; BJ3339; BJ 3340; BJ3341; BJ3342; BJ6282; BJ7192; BM8498; BJ7202; BJ7203, Exp 12/12
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pramipexole Dihydrochloride Tablets, 0.25 mg, 90-count tablets per bottle, Rx only, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ 08540, NDC 0781- 5249-92, recalled?

Yes. FDA published recall D-1677-2012 on September 26, 2012. Reported hazard: Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter